| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Preventive Health Services | 1 | 2012 | 75 | 0.390 |
Why?
|
| Heart Failure | 9 | 2006 | 2516 | 0.350 |
Why?
|
| Cardiomyopathy, Dilated | 6 | 2001 | 244 | 0.340 |
Why?
|
| Myocardial Ischemia | 3 | 2011 | 435 | 0.340 |
Why?
|
| Survivors | 4 | 2014 | 1031 | 0.330 |
Why?
|
| Quinazolines | 1 | 2011 | 923 | 0.280 |
Why?
|
| Radiation Injuries | 1 | 2012 | 1411 | 0.240 |
Why?
|
| Stroke | 1 | 2011 | 1144 | 0.220 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2004 | 257 | 0.210 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 323 | 0.200 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 2195 | 0.200 |
Why?
|
| Heart Block | 1 | 2000 | 48 | 0.190 |
Why?
|
| Cardiomyopathies | 2 | 2012 | 610 | 0.180 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2000 | 127 | 0.180 |
Why?
|
| Safety | 2 | 2001 | 465 | 0.180 |
Why?
|
| Radiotherapy | 3 | 2012 | 1824 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 1 | 2000 | 543 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2011 | 4757 | 0.160 |
Why?
|
| Subclavian Vein | 1 | 1998 | 35 | 0.160 |
Why?
|
| Phlebography | 1 | 1998 | 76 | 0.160 |
Why?
|
| Myocardium | 6 | 2009 | 1313 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 1997 | 192 | 0.150 |
Why?
|
| Antineoplastic Agents | 4 | 2012 | 14289 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2001 | 327 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 1998 | 263 | 0.130 |
Why?
|
| Muscle Proteins | 2 | 1999 | 549 | 0.130 |
Why?
|
| Defibrillators, Implantable | 1 | 1998 | 221 | 0.130 |
Why?
|
| Nerium | 1 | 2014 | 12 | 0.120 |
Why?
|
| Neoplasms | 4 | 2014 | 15193 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5319 | 0.120 |
Why?
|
| Research Design | 1 | 2000 | 1544 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2000 | 2594 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2014 | 215 | 0.110 |
Why?
|
| Coronary Angiography | 1 | 2014 | 598 | 0.100 |
Why?
|
| Endothelin Receptor Antagonists | 2 | 2001 | 22 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 2403 | 0.100 |
Why?
|
| Tetrazoles | 2 | 2001 | 106 | 0.090 |
Why?
|
| Prevalence | 2 | 2012 | 3260 | 0.090 |
Why?
|
| Anthracyclines | 1 | 2012 | 331 | 0.090 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2011 | 388 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 109 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 852 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1999 | 1538 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 11538 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 423 | 0.080 |
Why?
|
| Comorbidity | 2 | 2012 | 2352 | 0.080 |
Why?
|
| Risk Factors | 5 | 2012 | 17523 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 395 | 0.070 |
Why?
|
| Middle Aged | 18 | 2014 | 86204 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2010 | 1467 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 2008 | 240 | 0.070 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 176 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 1011 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 413 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 7551 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1429 | 0.070 |
Why?
|
| Humans | 28 | 2014 | 261506 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2009 | 329 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 499 | 0.060 |
Why?
|
| Pyrroles | 1 | 2009 | 576 | 0.060 |
Why?
|
| Hypertension | 2 | 2010 | 1503 | 0.060 |
Why?
|
| Adult | 12 | 2014 | 77950 | 0.060 |
Why?
|
| Pyridines | 2 | 2001 | 1244 | 0.060 |
Why?
|
| Indoles | 1 | 2009 | 1009 | 0.060 |
Why?
|
| Heart Transplantation | 2 | 2000 | 908 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2011 | 2295 | 0.050 |
Why?
|
| Patient Selection | 2 | 2000 | 2055 | 0.050 |
Why?
|
| Male | 17 | 2014 | 123000 | 0.050 |
Why?
|
| Hemodynamics | 3 | 2001 | 935 | 0.050 |
Why?
|
| Female | 17 | 2014 | 141928 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 1995 | 1471 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2001 | 2588 | 0.050 |
Why?
|
| Time Factors | 3 | 2012 | 12926 | 0.050 |
Why?
|
| Genotype | 3 | 1999 | 4109 | 0.050 |
Why?
|
| Texas | 1 | 2012 | 6311 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2002 | 151 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2002 | 495 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2014 | 1145 | 0.050 |
Why?
|
| Age Distribution | 1 | 2002 | 698 | 0.050 |
Why?
|
| Transplantation, Heterotopic | 1 | 1999 | 43 | 0.050 |
Why?
|
| Troponin T | 1 | 2001 | 261 | 0.040 |
Why?
|
| Prognosis | 4 | 2004 | 21713 | 0.040 |
Why?
|
| Echocardiography | 3 | 2012 | 1182 | 0.040 |
Why?
|
| Cardiac Output, Low | 1 | 1999 | 81 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2012 | 6869 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2012 | 32848 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2012 | 37905 | 0.040 |
Why?
|
| Phenotype | 3 | 2001 | 6295 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 1997 | 512 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2000 | 552 | 0.040 |
Why?
|
| Child | 3 | 2014 | 29154 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 161 | 0.040 |
Why?
|
| Cardiomegaly | 2 | 2001 | 195 | 0.040 |
Why?
|
| Piperazines | 1 | 2006 | 2101 | 0.040 |
Why?
|
| Aged | 8 | 2014 | 70117 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 106 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 1998 | 311 | 0.040 |
Why?
|
| Young Adult | 2 | 2012 | 21445 | 0.040 |
Why?
|
| Pedigree | 2 | 2001 | 1890 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2002 | 712 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1997 | 231 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1996 | 184 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 4320 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 31252 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 1546 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 1995 | 128 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2010 | 11965 | 0.030 |
Why?
|
| Cardenolides | 1 | 2014 | 22 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 473 | 0.030 |
Why?
|
| Exercise | 1 | 2002 | 1183 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 131 | 0.030 |
Why?
|
| Diet | 1 | 2002 | 1440 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2006 | 3518 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 223 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 132 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2014 | 110 | 0.030 |
Why?
|
| Procollagen | 1 | 1993 | 31 | 0.030 |
Why?
|
| Heart-Assist Devices | 2 | 2000 | 1171 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 3203 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 769 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 460 | 0.030 |
Why?
|
| Myocytes, Cardiac | 2 | 2009 | 764 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 6550 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 1450 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 709 | 0.020 |
Why?
|
| Contrast Media | 1 | 1998 | 1472 | 0.020 |
Why?
|
| Survival Rate | 2 | 2002 | 12221 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 1290 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2008 | 12873 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 52 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8865 | 0.020 |
Why?
|
| Quality of Life | 2 | 2000 | 4532 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2009 | 5270 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1995 | 1863 | 0.020 |
Why?
|
| Capillaries | 1 | 2009 | 99 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 133 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 289 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 2063 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 2001 | 1382 | 0.020 |
Why?
|
| Ultrasonics | 1 | 2008 | 69 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 265 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 4053 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 1549 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 276 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 248 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2054 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 1996 | 6150 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 6942 | 0.020 |
Why?
|
| United States | 1 | 2004 | 15433 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 58 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 118 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 395 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 197 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2006 | 72 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2010 | 627 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 122 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2006 | 191 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 4938 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 424 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2010 | 6100 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 6086 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 671 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 435 | 0.010 |
Why?
|
| Mass Screening | 1 | 2012 | 1509 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 4821 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 15694 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 14889 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 435 | 0.010 |
Why?
|
| Cell Survival | 1 | 2009 | 3045 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2006 | 1665 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2010 | 9244 | 0.010 |
Why?
|
| Mitochondria | 1 | 2009 | 1282 | 0.010 |
Why?
|
| Dobutamine | 1 | 2001 | 54 | 0.010 |
Why?
|
| Mutation | 1 | 2001 | 15179 | 0.010 |
Why?
|
| Receptor, Endothelin B | 1 | 2001 | 7 | 0.010 |
Why?
|
| Penetrance | 1 | 2001 | 126 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 2001 | 18 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2001 | 114 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2001 | 62 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 2001 | 73 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2001 | 60 | 0.010 |
Why?
|
| Breast | 1 | 2008 | 1344 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 3443 | 0.010 |
Why?
|
| Benzamides | 1 | 2006 | 1832 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2001 | 180 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 1963 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 159 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2001 | 200 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 997 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2008 | 3842 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1537 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 644 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 219 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 827 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 185 | 0.010 |
Why?
|
| Health Care Rationing | 1 | 2000 | 94 | 0.010 |
Why?
|
| Gene Expression | 2 | 1998 | 3570 | 0.010 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 1998 | 17 | 0.010 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 1998 | 14 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 1998 | 47 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2000 | 263 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 29902 | 0.010 |
Why?
|
| Exons | 1 | 2001 | 1328 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 5637 | 0.010 |
Why?
|
| Heart Rate | 1 | 2001 | 737 | 0.010 |
Why?
|
| MADS Domain Proteins | 1 | 1997 | 10 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 1997 | 35 | 0.010 |
Why?
|
| MEF2 Transcription Factors | 1 | 1997 | 47 | 0.010 |
Why?
|
| Forecasting | 1 | 2000 | 694 | 0.010 |
Why?
|
| Lod Score | 1 | 1997 | 157 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 1998 | 196 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 34495 | 0.010 |
Why?
|
| Acute Disease | 1 | 2001 | 2422 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 7702 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 2283 | 0.010 |
Why?
|
| Animals | 3 | 2009 | 59536 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2000 | 573 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 2803 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2000 | 795 | 0.010 |
Why?
|
| DNA Primers | 1 | 1997 | 1399 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1997 | 1163 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2001 | 1589 | 0.010 |
Why?
|
| Heart | 1 | 1999 | 1223 | 0.010 |
Why?
|
| Decision Making | 1 | 2000 | 1287 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1993 | 152 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1998 | 1265 | 0.010 |
Why?
|
| Organ Size | 1 | 1993 | 690 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 1099 | 0.010 |
Why?
|
| Alleles | 1 | 1997 | 2437 | 0.010 |
Why?
|
| Age Factors | 1 | 2000 | 5377 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1998 | 2022 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 6089 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 2483 | 0.010 |
Why?
|
| Palliative Care | 1 | 2000 | 2037 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 9180 | 0.010 |
Why?
|
| Body Weight | 1 | 1993 | 1293 | 0.000 |
Why?
|